Japanese collaborative study for fibrinogen assay: Variability of the fibrinogen assay between different laboratories does not improve when a common calibrator is used

Clinical and Laboratory Haematology

Volumn 27, Issue 3, 2005, Pages 177-183

  Takamiya, Osamu ^a   Hando, S ^b   Tekondo, M ^c   Bando, S ^d   Ohkura, M ^e   Negoro, T ^f   Yoshida, T ^g   Higashi, K ^h   Ohnuma, O ⁱ   Kubota, K ^j   Tatsumi, N ^k  

^a SHINSHU UNIVERSITY   (Japan)

^b MATSUMOTO DENTAL UNIVERSITY   (Japan)

^c Urasoe General Hospital   (Japan)

^d EHIME UNIVERSITY HOSPITAL   (Japan)

^e KAWASAKI MEDICAL SCHOOL   (Japan)

^f Rinku General Medical Center   (Japan)

^g KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^h UNIVERSITY OF TOKYO   (Japan)

ⁱ YAMAGATA UNIVERSITY   (Japan)

^j ASAHIKAWA MEDICAL COLLEGE   (Japan)

^k International Buddhist University   (Japan)

more..

Author keywords

Clauss method; Common calibrator; External quality control; Fibrinogen

Indexed keywords

FIBRINOGEN; REAGENT;

ANALYTICAL EQUIPMENT; ARTICLE; AUTOMATION; BLOOD CLOTTING TEST; CALIBRATION; CLINICAL LABORATORY; CONTROLLED STUDY; DEVICE; FIBRINOGEN BLOOD LEVEL; HUMAN; HUMAN TISSUE; JAPAN; PRIORITY JOURNAL; QUALITY CONTROL; STATISTICAL ANALYSIS;

CALIBRATION; FIBRINOGEN; HUMANS; JAPAN; LABORATORIES; PLASMA; QUALITY CONTROL; SENSITIVITY AND SPECIFICITY;

EID: 20444442750     PISSN: 01419854     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2257.2005.00686.x     Document Type: Article

References (22)

1. Acharya S.S., Coughlin A., Dimichele D.M. & North American Rare Bleeding Disorder Study Group (2004) Rare Bleeding Disorder Registry: deficiencies of factors II, V, VII, X, XIII, fibrinogen and dysfibrinogenemias. Journal of Thrombosis and Haemostasis 2, 248-256.
2. Chantarangkul V., Tripodi A. & Mannucci P.M. (1994) Results of a collaborative study for fibrinogen measurement. Evidence that the use of a common calibrator improves interlaboratory agreement. Blood Coagulation and Fibrinolysis 5, 761-766.
3. Committee of Quality Management on Japanese Society of Clinical Chemistry (2003) Trial of standardization for coagulation test. Japan Journal of Clinical Chemistry 32, 98-123 (Japanese).
4. Di Minno G. & Mancini M. (1990) Measuring plasma fibrinogen to predict stroke and myocardial infarction. Arteriosclerosis 10, 1-7.
5. Di Minno G., Cerbone A., Margaglione M., Vecchione G., Grandone E. & Mancini M. (1992) Fibrinogen and mechanisms of thrombosis. A difficult link. European Journal of Epidemiology 8(Suppl. 1), 88-91.
6. Ernst E. (1994) Fibrinogen: an important risk factor for atherothrombotic diseases. Annals of Medicine 26, 15-22.
7. Hirai N., Tatsumi N., Hino M., Yamane T. & Ohta K. (1998) Problems with assays based on fibrin clot formation principle: analysis of multilaboratory data. Osaka City Medical Journal 44, 55-57.
8. Japan Medical Association (2003) The 50th Official Report on the Results of External Quality Assessment Surveillance Conducted by the Japan Medical Association. Japan Medical Association, Tokyo, Japan (Japanese).
9. Jensen T., Halvorson S., Godak H.C. & Skjonsberg O.H. (2002) Influence of freeze-drying on the clotting properties of fibrinogen in plasma. Thrombosis Research 105, 499-502.
10. Mackie I.J., Kitchen S., Machin S.J., Lowe G.D. & Haemostasis and Thrombosis Task Force of the British Committee for Standards in Haematology (2003) Guidelines on fibrinogen assays. British Journal of Haematology 121, 396-404.
11. Montalescot G., Collet J.P., Choussat R. & Thomas D. (1998) Fibrinogen as a risk factor for coronary heart disease. European Heart Journal 19(Suppl H), H11-H17.
12. NCCLS (2001) NCCLS H30-A2: Procedure for the Determination of Fibrinogen in Plasma; Approved Guidelines. Second edition. Wayne, Pennsylvania.
13. Nagano Association of Medical Technologists (2003) The 19th Official Report on the Results of External Quality Assessment Surveillance Conducted by the Nagano Association of Medical Technologists. Nagano Association of Medical Technologists, Nagano, Japan (Japanese).
14. Okuda M., Uemura Y., Tatsumi N. & Honda S. (2003) Proposed fibrinogen standard material with purified fibrinogen for plasma fibrinogen measurement on coagulation analyzer. Journal of Automation Methods and Management in Chemistry 25, 103-107.
15. Okuda M., Uemura Y., Naka K. & Tatsumi N. (2003) Preparation of a purified fibrinogen calibration material for Clauss method and turbidimetric immunoassay possessing biological activity and antigenicity. Clinical and Laboratory Haematology 25, 167-172.
16. Okuda M., Uemura Y. & Tatsumi N. (2003) A new method of purifying fibrinogen with both biological and immunological activity from human plasma. Preparative Biochemistry and Biotechnology 33, 239-252.
17. Osaka Medical Association (2003) The 32nd Official Report on the Results of External Quality Assessment Surveillance Conducted by the Osaka Medical Association. Osaka Medical Association, Osaka, Japan (Japanese).
18. Standardization Committee, Hematology Subcommittee Japan Society of Laboratory Medicine (2001) Recommended procedures for the measurement of plasma fibrinogen proposed. Rinshobyori 49, 1273-1274 (Japanese).
19. Steigstra H., Jansen R.T. & Baadenhuijsen H. (1991) Combi scheme. New combined internal/external quality-assessment scheme in The Netherlands. Clinical Chemistry 37, 1196-1204.
20. UK National External Quality Assessment Scheme (NEQAS) (2000) UK National External Quality Assessment Scheme (NEQAS) for Blood Coagulation. Sheffield. UK.
21. Wada Y., Karashima T., Inoue M., Kawamura M., Kurihara M. & Masumoto M. (2003) Analytical goals for coagulation tests, hematological tests and biochemical tests based on biological variation. Japanese Journal of Clinical Chemistry 32, 200-209 (Japanese).
22. Yahe M. (2001) Standardization for coagulation test. A Collaborative study in the Fukuoka Prefecture. Japanese Journal of Clinical Chemistry 30 (Suppl.), 135-136 (Japanese).